Please use this identifier to cite or link to this item:
The replication kinetics of different strains of Marek's disease virus (MDV) and evaluation of the vaccine regime in Taiwan
|引用:||1 呂榮修。馬立克病。禽病診斷彩色圖譜。中華民國養雞協會。台北市。中華民國。255-263，1995。 2 李宗玄。台灣高病原性馬立克病毒之分離、鑑定及其防疫計劃之建立。國立中興大學。碩士論文。1995。 3 吳龍泰。馬立克病對肉雞影響之研究。國立中興大學。碩士論文。1997。 4 許添桓。台灣雞馬立克病毒之研究。國立中興大學。碩士論文。1989。 5 Abdul-Careem MF, Hunter BD, Nagy E, Read LR, Sanei B, Spencer JL, Sharif S. Development of a real-time PCR assay using SYBR Green chemistry for monitoring Marek’s disease virus genome load in feather tips. J Virol Methods 133: 34-40, 2006. 6 Anderson AS, Francesconi A, Morgan RW. Complete nucleotide sequence of the Marek’s disease virus ICP4 gene. Virology 189: 657–667, 1992. 7 Bacon LD, Witter RL, Silva RF. Characterization and experimental reproduction of peripheral neuropathy in White Leghorn chickens. Avian Patho 30: 487–499, 2001. 8 Baigent SJ, Davison TF. Marek’s disease virus: biology and life cycle. In: Davison, F., Nair, V. (Eds.), Marek’s Disease, an Evolving Problem. Elsevier Academic Press: 62–77, 2004. 9 Baigent SJ, Petherbridge LJ, Howes K, Smith LP, Currie RJW, Nair VK. Absolute quantitation of Marek’s disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123: 53-64, 2005. 10 Baigent SJ, Smith LP, Currie RJW, Nair VK. Replication kinetics of Marek’s disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation. J Gen Virol 86: 2989-2998, 2005. 11 Baigent SJ, Smith LP, Nair VK, Currie RJ. Vaccinal control of Marek''s disease: current challenges, and future strategies to maximize protection. Vet Immunol Immunopathol 112: 78-86, 2006. 12 Borenshtain R, Davidson I. Marek’s disease virus genome separation from feather tip extracts by plus field gel electrophoresis. J Virol Methods 101: 169-174, 2002. 13 Bradley G, Hayashi M, Lancz G, Tanaka M, Nonoyama M. Structure of the BamHI-H gene family: genes of putative importance in tumor induction. Journal of Virology 63: 2534–2542, 1989. 14 Buscaglia C, Nervi P, Risso M. Characterization of four very virulent Argentinian strains of Marek''s disease virus and the influence of one of those isolates on synergism between Marek''s disease vaccine viruses. Avian Pathol 33: 190-195, 2004. 15 Calnek BW. Pathogenesis of Marek’s disease virus infection. In: Hirai, K. (Ed.), Curr. Topics Microbiol Immunol 25–55, 2001. 16 Calnek BW, Adldinger HK, Kahn DE. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek’s disease. Avian Dis 14: 219–233, 1970. 17 Calnek BW, Hitchner SB, Adldinger HK. Lyophilization of cell-free Marek''s disease herpesvirus and a herpesvirus from turkeys. Appl Microbiol 20: 723-726, 1970. 18 Carrozza JH, Fredrickson TN, Prince RP, Luginbuhl RE. Role of desquamated epithelial cells in transmission of Marek’s disease. Avian Dis 17: 767–781, 1973. 19 Cebrian J, Kaschka-Dierich C, Berthelot N, Sheldrick P. Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey. Proceedings of the National Academy of Sciences 79: 555–558, 1982. 20 Chang KS, Lee SI, Ohashi K, Ibrahim A, Onuma M. Suppression of transcription activity of the MEQ protein of oncogenic Marek''s disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1. J Vet Med Sci 64: 1091-1095, 2002. 21 Chang KS, Lee SI, Ohashi K, Ibrahim A, Onuma M. The detection of the meq gene in chicken infected with Marek''s disease virus serotype 1. J Vet Med Sci 64: 413-417, 2002. 22 Chang KS, Ohashi K, Onuma M. Diversity (polymorphism) of the meq gene in the attenuated Marek''s disease virus (MDV) serotype 1 and MDV-transformed cell lines. J Vet Med Sci 64: 1097-1101, 2002. 23 Cho KO, Ohashi K, Onuma M. Electron microscopic and immunohistochemical localization of Marek’s disease (MD) herpesvirus particles in MD skin lymphomas. Vet Patho 36: 314–320, 1999. 24 Churchill AE, Biggs PM. Agent of Marek’s disease in tissue culture. Nature 215: 528–530, 1967. 25 Cui XP, Lee LF, Hunt HD, Reed WM, Lupiani B, Reddy SM. A Marek’s disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain. Avian Dis 49: 199-206, 2005. 26 Cui Z, Lee LF, Liu JL, Kung HJ. Structural analysis and transcriptional mapping of the MDV genome encoding pp38, an antigen associated with transformed cells. J Virol 65: 6509–6515, 1991. 27 Davison A. Comments on the phylogenetics and evolution of herpesviruses and other large DNA viruses. Virus Res 82: 127–132, 2002a. 28 Davison AJ. Evolution of the herpesviruses. Vet Microbiol 86: 69–88, 2002b. 29 Davidson I, Borenshtain R, Weisman Y. Molecular identification of the Marek’s disease virus vaccine strain CVI988 in vaccinated chickens. J Vet Med 49: 83-87, 2002. 30 Deluca NA, Schaffer PA. Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J Virol 62: 732–743, 1985. 31 Dudnikova E, Norkina S, Vlasov A, Slobodchuk A, Lee LF, Witter RL. Evaluation of Marek''s disease field isolates by the "best fit" pathotyping assay. Avian Pathol 36: 135-143, 2007. 32 Endoh D, Kon Y, Hayashi M, Morimura T, Cho KO, Iwasaki T, Sato F. Detection of transcripts of Marek''s disease virus serotype 1 iCP4 homologue (MDV1 ICP4) by in situ hybridization. J Vet Med Sci 58: 969-975, 1996. 33 Fragnet L, Blasco MA, Klapper W, Rasschaert D. The RNA subunit of telomerase is encoded by Marek’s disease virus. J Virol 77: 5985–5996, 2003. 34 Fukuchi K, Sudo M, Lee YS, Tanaka A, Nonoyama M. Structure of Marek’s disease virus DNA: detailed restriction enzyme map. J Virol 51: 102–109, 1984. 35 Gimeno IM. Marek’s disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression. Vet Pathol. 38: 491–503, 2001. 36 Gimeno IM, Witter RL, Reed WM. Four distinct neurologic syndromes in Marek’s disease: effect of viral strain and pathotype. Avian Dis 43: 721–737, 1999. 37 Hai TN, Liu F, Cuokos WJ, Green MR. Transcription factor ATF cDNA clones: an extensive family of leucine proteins able to selectively form DNA binding heterodimers. Genes and Development 3: 2083–2089, 1989. 38 Handberg KJ, Nielsen OL, Jorgensen PH. The use of serotype 1 and serotype 3 specific polymerase chain reaction for the detection of Marek’s disease virus in chickens. Avian Pathol 30: 243-249, 2001. 39 Hayashi M, Kawamura T, Akaike H, Arai S, Okul T. Antisense oligonucleotide complementary to the BamHI-H gene family of Marek’s disease virus induced growth arrest of MDCC-MSB1 cells in the Sphase. Journal of Veterinary Medical Science 61: 389–394, 1999. 40 Heidari M, Huebner M, Kireev D, Silva RF. Transcriptional profiling of Marek''s disease virus genes during cytolytic and latent infection. Virus Genes 36: 383-392, 2008. 41 Hunt HD. Marek’s disease virus down-regulates surface expression of MHC (B complex) class 1 (BF) glycoproteins during active but not latent infection of chicken cells. Virology 282: 198–205, 2001. 42 Isfort RJ, Kung HJ, Velicer LF. Identification of the gene encoding Marek’s disease herpesvirus A antigen. J Virol 61: 2614–2620, 1987. 43 Isfort RJ, Stringer RA, Kung HJ, Velicer LF. Synthesis, processing, and secretion of the Marek’s disease herpesvirus A antigen glycoprotein. J Virol 57: 464–474, 1986. 44 Islam AF, Walkden-Brown SW, Wong CW, Groves PJ, Burgess SK, Arzey KE, Young PL. Influence of vaccine deposition site on post-vaccinal viraemia and vaccination against Marek’s disease. Avian Pathol 30: 525-533, 2001. 45 Islam AF, Wong CW, Walkden-Brown SW, Colditz IG, Arzey KE, Groves PJ. Immunosuppressive effects of Marek''s disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge. Avian Pathol 31: 449-461, 2002. 46 Islam AFMF, Walkden-Brown SW, Islam A, Underwood GJ, Groves PJ. Relationship between Marek’s disease virus load in peripheral blood lymphocytes at varies stages of infection and clinical Marek’s disease in broiler chickens. Avian Pathol 35: 42-48, 2006. 47 Islam A, Cheetham BF, Mahony TJ, Young PL, Walkden-Brown SW. Absolute quantitation of Marek''s disease virus and Herpesvirus of turkeys in chicken lymphocyte, feather tip and dust samples using real-time PCR. J Virol Methods 132: 127-134, 2006. 48 Islam A, Harrison B, Cheetham BF, Mahony TJ, Young PL, Walkden-Brown SW. Differential amplification and quantitation of Marek''s disease viruses using real-time polymerase chain reaction. J Virol Methods 119: 103-113, 2004. 49 Islam A, Walkden-Brown SW. Quantitative profiling of the shedding rate of the three Marek’s disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. J Gen Virol 88: 2121-2128, 2007. 50 Isabel MG, Richard L, Witter RL, Henry DH, Sanjay MR, Willie MR. Biocharacteristics shared by highly protective vaccines against Marek’s disease. Avian Pathol 33: 59-68, 2004. 51 Jones D, Lee L, Liu JL, Kung HJ, Tillotson JK. Marek’s disease virus encodes a basic leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumours. Proceedings of the National Academy of Sciences 89: 4042–4046, 1992. 52 Johnson EA, Burke CN, Fredrickson TN, DiCapua RA. Morphogenesis of Marek’s disease virus in feather follicle epithelium. J Natl Cancer Inst. 55: 89–99, 1975. 53 Kamil JP. vLIP, a viral lipase homologue, is a virulence factor of Marek’s disease virus. J Virol 79: 6984–6996, 2005. 54 Kawamora M, Hayashi M, Furuichi T, Nonoyama M, Isogai E, Namioka S. The inhibitory effects of oligonucleotides, complementary to the Marek’s disease virus mRNA transcribed from the BamHI-I region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1. J Gen Virol 72: 1105–1111, 1991. 55 Kingham BF. The genome of herpesvirus of turkeys: comparative analysis with Marek’s disease viruses. Journal of General Virology 82: 1123–1135, 2001. 56 Koppers-Lalic D. Varicelloviruses avoid T cell recognition by UL49.5 mediated inactivation of the transporter associated with antigen processing. Proceedings of the National Academy of Sciences 102: 5144–5149, 2005. 57 Kuhnlein U, Spencer JL, Chan M, Praslickova D, Linher K, Kulenkamp A, Ansah G. Relationship between Marek''s disease and the time course of viral genome proliferation in feather tips. Avian Dis 50: 173-178, 2006. 58 Lee LF, Lupiani B, Silva RF, Kung HJ, Reddy SM. Recombinant Marek''s disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26: 1887-1892, 2008. 59 Lee SI, Takagi M, Ohashi K, Sugimoto C, Onuma M. Difference in the meq gene between oncologenic and attenuated strains of Marek’s disease virus serotype 1. Virology 62: 287-292, 2000. 60 Lin JA, Chen CP. First isolation and characterization of very virulent Marek’s disease virus in Taiwan. J Vet Med Sci 58: 1011-1015, 1996. 61 Lin JA, Lee TS. Genetic susceptibility to Marek’s Disease virus of local chickens in Taiwain. Avian Dis 40: 6576-581, 1996. 62 Lin JA, Lee TS. Protectivity of the bivalent Marek’s disease vaccines in Taiwain local chickens. J Chin Soc Vet Sci 22: 107-112, 1996. 63 Liu JL, Ye Y, Lee LF, Kung HJ. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum independent growth, and inhibition of apoptosis. J Virol 72, 388–395, 1998. 64 Liu JL, Lin SF, Xia L, Brunovskis P, Li D, Davidson I, Lee LF, Kung HJ. MEQ and v-IL8: cellular genes in disguise? Acta Virologica. 43: 94–101, 1999. 65 Lucia GC, Karel AS, Randolph BJ, Denise IB. Early cell-mediated immune responses to Marek’s disease virus in two chicken lines with defined major histocompatibility complex antigens. Vet Immunol Immunopathol 95: 145-153, 2003. 66 Lupiani B, Lee LF, Cui X, Gimeno I, Anderson A, Morgan RW, Silva RF, Witter RL, Kung HJ, Reddy SM. Marek''s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc Natl Acad Sci U S A 101: 11815-11820, 2004. 67 Marek, J. Multiple Nervenentzundung (Polyneuritis) bei Huhnern. Dtsch Tierarztl Wochenschr. 15: 417–421, 1907. 68 Mohammadi A, Spencer JL, Chan M, Ansari Lari M. Antibody response of chickens to serotype 1, 2, or 3 Marek''s disease vaccines based on ELISA with infected cells as antigen. Avian Dis 51: 982-985, 2007. 69 Murata S, Chang KS, Lee SI, Konnai S, Onuma M, Ohashi K. Development of a nested polymerase chain reaction method to detect oncogenic Marek''s disease virus from feather tips. J Vet Diagn Invest 19: 471-478, 2007. 70 Murata S, Chang KS, Yamamoto Y, Okada T, Lee SI, Konnai S, Onuma M, Osa Y, Asakawa M, Ohashi K. Detection of the virulent Marek''s disease virus genome from feather tips of wild geese in Japan and the Far East region of Russia. Arch Virol 152: 1523-1526, 2007. 71 Nakajima K, Ikuta K, Ueda S, Kato S, Hirai K. Identification with monoclonal antibodies of virus-specific DNA-binding proteins in the nuclei of cells infected with three serotypes of Marek''s disease virus-related viruses. J Virol 59: 154-158, 1986. 72 Niikura M, Dodgson JB, Cheng HH. Stability of Marek''s disease virus 132-bp repeats during serial in vitro passages. Arch Virol 151: 1431-1438, 2006. 73 Qian Z, Brunovskis P, Rauscher F, Lee L, Kung HJ. The transactivation activity of Meq, a Marek’s disease herpesvirus bZIP protein persistently expressed in latently-infected transformed T-cells. J Virol 69: 4037–4044, 1995. 74 Qian Z, Brunovskis P, Lee L, Vogt PK, Kung HJ. Novel DNA binding properties of a putative herpesvirus bZIP oncoprotein. J Virol 70: 7161–7170, 1996. 75 Okada T, Takagi M, Murata S, Onuma M, Ohashi K. Identification and characterization of a novel spliced form of the meq transcript in lymphoblastoid cell lines derived from Marek''s disease tumours. J Gen Virol 88: 2111-2120, 2007. 76 Ono M, Kawaguchi Y, Maeda K, Kamiya N, Yohya Y, Kai C, Niikura M, Mikami T. Nucleotide sequence analysis of Marek’s disease virus (MDV) serotype 2 homolog of MDV serotype 1 pp38, an antigen associated with transformed cells. Virology 201: 142–146, 1994. 77 Parcells MS. Marek’s disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75: 5159–5173, 2001. 78 Peng F, Donovan J, Specter S, Tanaka A, Nonoyama M. A 7 kDa protein encoded by the BamHI-H gene family of Marek’s disease virus is produced in lytically and latently infected cells. International Journal of Oncology 4: 799–802, 1994. 79 Peng QH, Shirazi Y. Characterization of the protein product encoded by a splicing variant of the Marek’s disease virus Eco-Q gene (Meq). Virology 226, 77–82, 1996. 80 Peng Q, Zeng M, Bhuiyan ZA, Ubukata E, Tanaka A, Nonoyama M, Shirazi Y. Isolation and characterization of Marek’s disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2 and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213: 590–599, 1995. 81 Reem Y, Keith WJ, Karel AS. Association between rate of viral genome replication and virulence of Marek''s disease herpesvirus strains. Virology 328: 142-150, 2004. 82 Renz KG, Islam A, Cheetham BF, Walkden-Brown SW. Absolute quantification using real-time polymerase chain reaction of Marek''s disease virus serotype 2 in field dust samples, feather tips and spleens. J Virol Methods 135: 186-191, 2006. 83 Ross LJN. T-cell transformation by Marek’s disease virus. Microbiology: 22–29, 1999. 84 Ross LJN, Basarab O, Walker DJ, Whitby B. Serological relationship between a pathogenic strain of Marek’s disease virus, its attenuated derivative and herpes virus of turkeys. J Gen Virol 28: 37–47, 1975. 85 Ross N, O’Sullivan G, Rothwell C, Smith G, Burgess SC, Rennie M, Lee LF, Davison TF. Marek’s disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek’s disease lymphomas. J Gen Virol 78: 2191–2198, 1997. 86 Ross NL, DeLorbe W, Varmus HE, Bishop JM, Brahic M, Haase A. Persistence and expression of Marek''s disease virus DNA in tumour cells and peripheral nerves studied by in situ hybridization. J Gen Virol 57: 285-296, 1981. 87 Schat KA. Isolation of Marek''s disease virus: revisited. Avian Pathol 34: 91-95, 2005. 88 Schat KA, Buckmaster A, Ross LJN. Partial transcription map of Marek’s disease herpesvirus in lytically infected cells and lymphoblastoid cell lines. International Journal of Cancer 44: 101–109, 1989. 89 Shamblin CE, Greene N, Arumugaswami V, Dienglewicz RL, Parcells MS. Comparative analysis of Marek''s disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Vet Microbiol 102: 147-167, 2004. 90 Sharma JM, Zhang Y, Jensen D, Rautenschlein S, Yeh HY. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek''s disease, infectious bursal disease, Newcastle disease, and fowl pox. Avian Dis 46: 613-622, 2002. 91 Silva RF, Witter RL. Genomic expansion of Marek’s disease virus DNA is associated with serial in vitro passage. J Virol 54: 690–696, 1985. 92 Sugaya K, Bradley G, Nonoyama M, Tanaka A. Latent transcripts of Marek’s disease virus are clustered in the short and long repeat regions. J Virol 64: 5773–5782, 1990. 93 Sung HW. Reccent increase of Marek’s disease in Korea related to the virulence increase of the virus. Avian Dis 46: 517-524, 2002. 94 Tan J, Cooke J, Clarke N, Tannock GA. Optimization of methods for the isolation of Marek''s disease viruses in primary chicken cell cultures. J Virol Methods 147: 312-318, 2008. 95 Tischer, BK. High-level expression of Marek’s disease virus glycoprotein C is detrimental to virus growth in vitro. J Virol 79: 5889–5899, 2005. 96 Tulman, ER. The genome of a very virulent Marek’s disease virus. J Virol 74: 7980–7988, 2000. 97 Vallejo RL, Bacon LD, Liu HC, Witter RL, Groenen MA, Hillel J, Cheng HH. Genetic mapping of quantitative trait loci affecting susceptibility to Marek''s disease virus induced tumors in F2 intercross chickens. Genetics 148: 349-360, 1998. 98 Venugopal K. Marek''s disease: an update on oncogenic mechanisms and control. Res Vet Sci 69: 17-23, 2000. 99 Witter RL. Increased virulence of Marek’s disease virus field isolates. Avian Dis 41: 149-163, 1997. 100 Witter RL. Induction of strong protection by vaccination with partially attenuated serotype 1 Marek''s disease viruses, Avian Dis 46: 925–937, 2002. 101 Witter RL. Very virulent Marek’s disease viruses: importance and control. Worlds Poult Sci 26: 658-668, 1970. 102 Witter RL, Gimeno IM. Susceptibility of adult chickens, with and without prior vaccination, to challenge with Marek''s disease virus. Avian Dis 50: 354-365, 2006. 103 Witter RL, Gimeno IM, Reed WM, Bacon LD. An acute form of transient paralysis induced by highly virulent strains of Marek’s disease virus. Avian Dis 43: 704–720, 1999. 104 Witter RL, Sharma JM, Fadly AM. Pathogenicity of variant Marek’s disease virus isolates in vaccinated and unvaccinated chickens. Avian Dis 24: 210-231, 1980. 105 Witter RL, Sharma JM, Lee LF, Opitz HM, Henry CW. Field trials to test the efficacy of polyvalent Marek''s disease vaccines in broilers. Avian Dis 28: 44-60, 1984. 106 Xie Q, Anderson AS, Morgan RW. ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J Virol 70: 1125–1131, 1996.|
|摘要:||馬立克病（Marek’s disease, MD）是一種雞的傳染性致腫瘤性疾病，由馬立克病毒（Marek’s disease virus, MDV）引起，造成T細胞淋巴瘤。自1970年MD活毒疫苗開始使用後，已大幅降低馬立克疫情所造成的經濟損失。然而，MDV的毒力日益增強，從疫苗接種過的雞群中陸續分離到超強毒株vvMDV（very virulent MDV），故重新檢討台灣現階段的免疫計畫是很重要的。因此本實驗目的為研究MDV的病毒複製動力學，選用市售疫苗CVI988、HVT以及本實驗室所分離到的野外分離株DW-1，來觀察疫苗株與野外株，彼此間複製動力學的相關性，在病毒接種後1-20天，間隔2天採樣一次，每次共採集14個臟器樣本，利用PCR診斷技術來偵測病毒核酸的存在，同時也觀察疫苗接種對於DW-1病毒複製的影響。結果顯示疫苗接種對於DW-1的早期複製有抑制的效果，這可以幫助我們進一步了解疫苗在各臟器中的分佈情形與保護效力，我們也利用腎臟組織細胞（Chicken kidney cell, CKC）來觀察比較病毒於 in vivo 和 in vitro 的生長情形，於攻毒後第二週、第三週和第四週，將攻毒的雞隻以人道方式犧牲取其腎臟作初代組織培養，計算PFU（Plaque formation unit）的生成數量，結果顯示疫苗對於DW-1的病毒複製能力有些微的抑制效果，但是抑制能力也有限，最終無法抑制攻毒的雞隻發病，這結果與 in vivo 試驗相符合，這些發現有助於日後疫苗計畫的擬定，發展一套更好的馬立克防疫策略，將疾病造成的經濟損失降至最低。|
Marek's disease (MD) is one of the most contagious oncogenic lymphotrophic diseases in chicken caused by MDV. In past 30 years, the use of MDV live vaccines have greatly reduced the economic losses from MD. However, vaccines themselves are thought to be responsible for driving the virulence. After the isolation of very virulent MDV (vvMDV) from vaccinated flocks, it is important to evaluate recent vaccine regimes in Taiwan. To investigate the correlation between virus replication kinetics and vaccination, viruses from vaccine strains CVI988 (Rispens), HVT, and very virulent strain DW-1 were used to evaluate virus replication kinetics. We used PCR technique to detect virus in 14 organs in day 1-20 post-vaccination at two-day interval. We also detected the virus of DW-1 and vaccine strains when challenged with or without vaccination. The results showed that the existence of vaccine strains can in vivo reduce the replication of field strain. However, chicken challenged with DW-1 strain enhanced the growth of HVT vaccine strain. It may help us to realize the correlation between vaccine level in different organs and protection. Moreover, we also used the CKC from challenged chickens with or without vaccination to compare the challenge virus yield. Specific plaques were calculated at 14-day after culture from each one, and the plaques of the very virulent DW-1 strain in infected chicken kidney cultures were shown significantly more than other cultures from HVT vaccinated chicken, the results indicated that the growth of field isolate was reduced in vaccinated chicken, in accordance to in vivo test. These findings are useful for developing the vaccine regime of MD in Taiwan.
|Appears in Collections:||獸醫學系所|
Show full item record
TAIR Related Article
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.